Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Lamotrigine Effects on Breastfed Infants Pubmed



Dalili H1 ; Nayeri F1 ; Shariat M2 ; Asgarzadeh L3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neonatology, Breast Feeding Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Maternal and Child Health, Maternal-Fetal-Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medicine, Breast Feeding Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Medica Iranica Published:2015


Abstract

Lamotrigine is a safe anti-epileptic drug among pregnant and lactating women. Some concerns exist regarding the safety of lamotrigine during breastfeeding and related neonatal complications. In this brief review, this matter was evaluated and discussed. In this review study, the medical literature available in search databases such as Embase, Scopus, PubMed, and Medline and even also local medical search engines were evaluated. The results indicated that lamotrigine is a safe anti-epileptic drug for breastfeeding women with rare and usually mild adverse effects among neonates exposed to high milk concentration of this drug and its metabolites. However, close periodical monitoring for infants whose mothers are utilizing lamotrigine is recommended to decrease the probability of severe side effects among them. © 2015 Tehran University of Medical Sciences. All rights reserved.